Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Translational Medicine|June 22, 2019
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinomaYui Hirata-Nozaki, Takayuki Ohkuri, Kenzo Ohara, et al.
Cancer Science|January 27, 2024
Soluble CD27 as a predictive biomarker for intra-tumoral CD70/CD27 interaction in nasopharyngeal carcinomaToshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, et al.
Cancer Research Communications|November 24, 2025
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1-Mutant Lung CancerToshiyuki Tenma, Ryohei Yoshida, Hiraku Yanada, et al.
The Journal of Experimental Medicine|September 24, 2021
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytesAkemi Kosaka, Kei Ishibashi, Toshihiro Nagato, et al.
Oncology Letters|April 12, 2021
The feasibility of circulating tumor DNA analysis as a marker of recurrence in triple-negative breast cancerSatoshi Okazaki, Takaaki Sasaki, Shunsuke Yasuda, et al.
Cancer Immunology, Immunotherapy : CII|June 25, 2025
Tumor-promoting function of paternally expressed gene 10 and its immunogenicity in inducing anti-tumor helper T cells in head and neck squamous cell carcinomaHiroki Komatsuda, Toshihiro Nagato, Akemi Kosaka, et al.
Cancer Immunology, Immunotherapy : CII|March 29, 2017
Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapyToshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara, et al.
Oncoimmunology|January 18, 2021
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinomaRyusuke Hayashi, Toshihiro Nagato, Takumi Kumai, et al.
Cancer Immunology, Immunotherapy : CII|February 22, 2023
Expression of soluble CD27 in extranodal natural killer/T-cell lymphoma, nasal type: potential as a biomarker for diagnosis and CD27/CD70-targeted therapyToshihiro Nagato, Hiroki Komatsuda, Ryusuke Hayashi, et al.
Acta Neuropathologica|May 15, 2024
Aberrant CHCHD2-associated mitochondriopathy in Kii ALS/PDC astrocytesNicolas Leventoux, Satoru Morimoto, Mitsuru Ishikawa, et al.
Pageof 10